CUOMO, ONOFRIO
 Distribuzione geografica
Continente #
EU - Europa 99
NA - Nord America 90
AS - Asia 34
SA - Sud America 6
AF - Africa 1
Totale 230
Nazione #
US - Stati Uniti d'America 87
IT - Italia 63
SG - Singapore 28
DE - Germania 12
BR - Brasile 6
FI - Finlandia 6
GB - Regno Unito 5
NL - Olanda 5
SE - Svezia 3
CA - Canada 2
CZ - Repubblica Ceca 2
IN - India 2
RU - Federazione Russa 2
CN - Cina 1
FR - Francia 1
IR - Iran 1
LB - Libano 1
TT - Trinidad e Tobago 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 230
Città #
Chandler 16
Singapore 15
Carbonia 12
Munich 11
Chicago 10
Ashburn 5
London 5
Turku 5
Ercolano 4
Santa Clara 4
Lawrence 3
Paola 3
Princeton 3
Rome 3
Afragola 2
Delhi 2
Gesuiti 2
Olomouc 2
Reggio Calabria 2
San Nicola Manfredi 2
Alvorada 1
Baturité 1
Beirut 1
Benevento 1
Boardman 1
Chaguanas 1
Charlotte 1
Cosenza 1
Crestview 1
Hanoi 1
Helsinki 1
Indian Trail 1
Jinhua 1
Johannesburg 1
Memphis 1
Milan 1
Montreal 1
Naples 1
Norwich 1
Nuremberg 1
Palermo 1
San Francisco 1
Seattle 1
St Petersburg 1
Stockholm 1
São Paulo 1
Taubaté 1
Ubá 1
Votuporanga 1
Wilmington 1
Totale 141
Nome #
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 81
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 69
Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab, a case report 38
The antiepileptic drug levetiracetam suppresses non-convulsive seizure activity and reduces ischemic brain damage in rats subjected to permanent middle cerebral artery occlusion 30
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 25
Totale 243
Categoria #
all - tutte 1.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.975


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 1 0 0 0 0 0 0 0 0
2021/202219 0 0 0 1 1 0 1 1 9 6 0 0
2022/202346 6 6 1 2 7 4 0 3 9 3 3 2
2023/202443 19 4 4 1 2 7 0 0 0 0 3 3
2024/2025124 7 3 1 5 8 14 6 3 10 2 32 33
2025/202610 10 0 0 0 0 0 0 0 0 0 0 0
Totale 243